ATIP-AVENIR, Inserm U995, Université Lille Nord de France, 152 rue du Docteur Yersin, 59120 Loos, France.
J Clin Virol. 2011 Sep;52(1):4-10. doi: 10.1016/j.jcv.2011.05.016. Epub 2011 Jun 15.
Three pathogens account for most cases of occupationally acquired blood-borne infection: hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV). The highest proportion of occupational transmission is due to percutaneous injury (PI) via hollow-bore needles with vascular access. We briefly review prevention and management of blood-borne pathogens in health care workers (HCWs) in developed countries. HCW compliance with standard precautions is necessary for prevention of PI. Safety-engineered devices are now being increasingly promoted as an approach to decreasing the rate of PI. Prevention of HBV transmission requires HCW immunization through vaccination against HBV. In non-vaccinated HCWs (or HCWs with an unknown antibody response to vaccination) exposed to an HbsAg-positive or an untested source patient, post-exposure prophylaxis with HBV vaccine, hepatitis B immunoglobulin or both must be started as soon as possible. Although no available prophylaxis exists for HCV, it is crucial to identify HCV exposure and infection in health care settings and to consequently propose early treatment when transmission occurs. Following occupational exposure with potential for HIV transmission, use of antiretroviral post-exposure prophylaxis must be evaluated. Patients need to be protected from blood-borne pathogen-infected HCWs, and especially surgeons performing exposure-prone procedures (EPPs) with risk of transmission to the patient. However, HCWs not performing EPPs should be protected from arbitrary administrative decisions that would restrict their practice rights. Finally, it must be emphasized that occupational blood exposure is of great concern in developing countries, with higher risk of exposure to blood-borne viruses because of a higher prevalence of the latter than in developed countries, re-use of needles and syringes and greater risk of sustaining PI, since injection routes are more frequently used for drug administration than in developed countries.
乙型肝炎病毒 (HBV)、丙型肝炎病毒 (HCV) 和人类免疫缺陷病毒 (HIV)。职业性传播的比例最高是由于空心针具的经皮损伤 (PI) 导致的,这些空心针具具有血管通道。我们简要回顾了发达国家医护人员 (HCW) 中血源性病原体的预防和管理。HCW 遵守标准预防措施是预防 PI 的必要条件。安全工程设备现在越来越多地被推广作为降低 PI 发生率的一种方法。预防 HBV 传播需要通过接种 HBV 疫苗对 HCW 进行免疫。对于未接种疫苗的 HCW(或对疫苗接种无已知抗体反应的 HCW)暴露于 HbsAg 阳性或未经检测的源患者,应尽快开始使用 HBV 疫苗、乙型肝炎免疫球蛋白或两者联合进行暴露后预防。虽然目前尚无针对 HCV 的可用预防措施,但在医疗保健环境中识别 HCV 暴露和感染并在发生传播时尽早提出治疗方案至关重要。职业性暴露后有发生 HIV 传播的可能时,必须评估使用抗逆转录病毒暴露后预防措施。需要保护患者免受携带血源性病原体的 HCW 感染,特别是在进行具有传播风险的暴露性手术 (EPP) 的外科医生。然而,不应限制未进行 EPP 的 HCW 的实践权利,除非有任意行政决定需要保护他们。最后,必须强调的是,发展中国家职业性血液暴露问题令人担忧,由于这些国家的血液传播病毒流行率较高,重复使用针具和注射器以及 PI 风险较高,与发达国家相比,注射途径更常用于药物管理,因此接触血源性病原体的风险更高。